The methods developed by the present inventors can produce significantly increased numbers of endothelial cells as compared to existing approaches. Advantageously, methods of the invention allow for the production of sufficient numbers of endothelial cells for downstream cell therapy applications.
- Producing substantial quanti-ties of endothelial cells in vitro under non-human animal derived component free conditions.
- The cells have a range of therapeutic applications (ex. Cell therapy and/or trans-plantation)
- Scalable production of large numbers of endothelial cells in compliance with GMP standards.
This technology is subject to Priority patent application.
+44 (0)20 7594 6866